Related Experiment Videos
Molecular biology of laryngeal squamous cell carcinoma
Alfons Nadal1, Antonio Cardesa
1Department of Anatomia Patologica, Hospital Clínic, Universitat de Barcelona, Villarroel 170, 08036, Spain.
Abstract:
Some of the mechanisms involved in neoplastic transformation and progression of laryngeal squamous cell carcinoma (LSCC) are discussed. Although tumor suppressor inactivation of p53 and p16 is common in these tumors (about 50% each), oncogenic activation is less well characterized. Cyclin D1 and epidermal growth factor receptor amplification have been reported in one-third and one-quarter of LSCCs, respectively, both related to advanced stages, whereas c-myc could be amplified in 13% of cases although without associated overexpression. The role of ras in LSCC is, at most, exceptional, and the role of human papillomavirus infection in these neoplasms could have been largely overestimated. The AIS (amplified in squamous carcinoma) gene has been recently proposed as the main oncogenic target in head and neck squamous carcinomas and is a promising line of investigation. This, along with the link that exists between p53 and INK4 suppressor pathways through ARF and MDM-2, and the role of the universal cdk inhibitors (the Cip/Kip family) in these neoplasms deserve further investigation. Not forgotten are the mechanisms leading to cell immortalization and invasive capabilities acquisition, some of which are also briefly described.
Insights
Mechanisms of laryngeal squamous cell carcinoma (LSCC) progression are explored. While tumor suppressor genes like p53 are often inactivated, oncogenic activation requires further study, with AIS gene a promising target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Laryngeal squamous cell carcinoma (LSCC) progression involves complex genetic alterations.
- Understanding these molecular mechanisms is crucial for developing targeted therapies.
Purpose of the Study:
- To review and discuss the key mechanisms driving neoplastic transformation and progression in LSCC.
- To highlight potential oncogenic targets and pathways for further investigation.
Main Methods:
- Literature review and synthesis of existing research on genetic alterations in LSCC.
- Analysis of common mutations, amplifications, and their correlation with tumor stage.
Main Results:
- Tumor suppressor inactivation (p53, p16) is frequent (~50%).
- Oncogene amplification (Cyclin D1, EGFR, c-myc) occurs in a subset of LSCCs, often linked to advanced stages.
- The role of Ras is minimal, and HPV's contribution may be overestimated.
- The AIS gene is a potential key oncogenic target in head and neck squamous cell carcinomas.
Conclusions:
- Further research into p53/INK4 pathways, ARF, MDM-2, and CDK inhibitors (Cip/Kip family) is warranted.
- Investigating mechanisms of cell immortalization and invasion is essential for a comprehensive understanding of LSCC.
- The AIS gene represents a promising avenue for LSCC research and therapeutic targeting.